First Patient Dosed in Study of Cell Therapy for Gastric Cancer

October 30, 2023

From BioPharma Reporter
Triumvira Immunologics, a Texas-based clinical-stage company developing T cell therapeutics to treat patients with solid tumors, has announced that the first patient has been dosed in its phase 2 trial to treat gastric cancer.